当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析

安科生物

(300009)

  

流通市值:110.73亿  总市值:152.72亿
流通股本:12.16亿   总股本:16.76亿

安科生物(300009)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.00亿元,每股收益0.35元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益413241.03万元,未分配利润156956.97万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产499097.85万元,负债85856.82万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,921,280,101.121,298,815,000.98656,092,096.172,865,752,059.95
营业总成本1,268,341,322.03842,210,918.23412,632,143.811,930,498,177.72
营业利润699,364,367492,996,844.14257,600,663.55923,979,111.22
利润总额698,275,336.46492,018,081.44257,619,264.62919,929,605.88
净利润599,915,131.57423,770,648.17221,942,342.95858,588,991.57
其他综合收益----
综合收益总额599,915,131.57423,770,648.17221,942,342.95858,588,991.57
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,240,715,100.012,161,578,860.882,512,247,494.212,325,483,458.75
非流动资产合计2,750,263,372.72,683,092,986.592,614,458,147.182,625,277,027.29
资产总计4,990,978,472.714,844,671,847.475,126,705,641.394,950,760,486.04
流动负债合计699,754,762.31739,846,515.21793,045,617.92847,080,888.86
非流动负债合计158,813,455.35154,519,846.06167,764,792.3171,347,690.88
负债合计858,568,217.66894,366,361.27960,810,410.221,018,428,579.74
归属于母公司股东权益合计3,937,686,124.913,750,250,207.423,966,402,036.483,737,399,547.01
股东权益合计4,132,410,255.053,950,305,486.24,165,895,231.173,932,331,906.3
负债和股东权益合计4,990,978,472.714,844,671,847.475,126,705,641.394,950,760,486.04
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,875,989,512.271,235,075,413.48623,525,658.512,567,892,245.45
经营活动现金流出小计1,455,085,023.091,029,267,158.07468,795,288.461,614,921,345.87
经营活动产生的现金流量净额420,904,489.18205,808,255.41154,730,370.05952,970,899.58
投资活动现金流入小计1,160,526,336.561,031,542,969.92905,331,713.15872,931,734.08
投资活动现金流出小计1,044,603,561.67827,399,567.961,002,074,899.51,490,203,341.36
投资活动产生的现金流量净额115,922,774.89204,143,401.96-96,743,186.35-617,271,607.28
筹资活动现金流入小计5,000,0005,000,000-41,057,576
筹资活动现金流出小计449,876,950.15432,138,5252,197,333.4442,051,672.55
筹资活动产生的现金流量净额-444,876,950.15-427,138,525-2,197,333.4-400,994,096.55
汇率变动对现金及现金等价物的影响47,093.95159,350.0913,564.21-107,327.13
现金及现金等价物净增加额91,997,407.87-17,027,517.5455,803,414.51-65,402,131.38
期末现金及现金等价物余额350,781,357.61241,756,432.2314,587,364.25258,783,949.74
最新报告期:2024-09-03
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国盛证券张金洋0.540.640.752024-09-03
国金证券袁维0.640.811.012024-08-28
TOP↑